HOME
ABOUT US
TECHNOLOGY
PIPELINE
PARTNERSHIP
MEDIA
RECRUITMENT
CONTACT
NEWS REPORT
GeneQuantum and WuXi XDC have entered into strategic cooperation to empower innovative bioconjugates development
Forge Stronger Partnership for Advanced ADC Development! GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs
GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development
01
Strategic Cooperation between GeneQuantum Healthcare and Biocytogen on Development of Antitumor Bioconjugates
Genequantum Successfully Granted a "Unicorn-to-be" Company
Global first iLDC enabling ADC drug receives IND approval by NMPA
GeneQuantum Healthcare was awarded the honorary title of " Unicorn-to-be" in Jiangsu Province and the recognition of "Enterprise Technology Center" in Suzhou
GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate
